Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi‐center retrospective case series

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

(2018) T. Zuberbier et al.   ALLERGY

Update on Omalizumab for Urticaria: What’s New in the Literature from Mechanisms to Clinic

(2018) Désirée E. S. Larenas-Linnemann et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients

(2018) Maria-Magdalena Balp et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Management of Pediatric Urticaria with Review of the Literature on Chronic Spontaneous Urticaria in Children

(2018) Moshe Ben-Shoshan et al.   Journal of Allergy and Clinical Immunology-In Practice

Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria

(2018) Jason Kihyuk Lee et al.   Journal of Allergy and Clinical Immunology-In Practice

Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients

(2017) Zahava Vadasz et al.   Journal of Allergy and Clinical Immunology-In Practice

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis

(2013) Martin Metz et al.   JOURNAL OF DERMATOLOGICAL SCIENCE